Skip to Content
Merck
CN

900656

Methoxy poly(ethylene glycol)-b-poly(L-lactide)

5k-10k

Synonym(s):

mPEG-b-PLA, mPEG-PLA, mPEG-PLLA

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
HO[CH(CH3)COO]m[CH2CH2O]nCH3
NACRES:
NA.23
UNSPSC Code:
12162002
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Methoxy poly(ethylene glycol)-b-poly(L-lactide), 5k-10k

form

solid

storage temp.

2-8°C

Quality Level

Looking for similar products? Visit Product Comparison Guide

Application

Biocompatible, amphiphilic block copolymer composed of a hydrophilic PEG block and a hydrophobic poly(L-lactide) (PLLA) block. These materials have been used in control release and nanoparticle formulation for drug encapsulation and delivery applications. Well-defined materials with varying properties can be prepared by controlling the relative length of each polymer block. Hydroxyl termination allows for facile further chemical modification of these materials.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

>230.7 °F

flash_point_c

> 110.4 °C

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Injectable biodegradable polymeric system for preserving the active form and delayed-release of camptothecin anticancer drugs.
Mert O, et al.
Royal Society of Chemistry Advances, 2(1), 176-185 (2012)
Zhigang Xie et al.
Journal of biomedical materials research. Part A, 88(1), 238-245 (2008-02-21)
Docetaxel (DX) is one of the most effective antineoplastic drugs. Its current clinical administration is limited because of its hydrophobicity and serious side effects. A polymer/DX conjugate is designed and successfully prepared to solve these problems. It is monomethoxy-poly(ethylene glycol)-block-poly(L-lactide)/DX

Articles

The development of drugs that target specific locations within the human body remains one of the greatest challenges in biomedicine today.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service